Trial intelligence / Profile preview

Melatonin in Type 2 Diabetic Patients With Peripheral Neuropathy

NCT07036796Phase 2Recruiting

Sponsor
Ain Shams University
Start
Jul 2025
Primary completion
Jul 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of melatonin in diabetic peripheral neuropathy (DPN), sponsored by Ain Shams University. Started Jul 2025; status: recruiting.

02

Drugs

melatonin
03

Conditions

diabetic peripheral neuropathy (DPN)

Beyond the preview

Go deeper on NCT07036796.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07036796.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call